Quince Therapeutics
QNCX
QNCX
83 hedge funds and large institutions have $715M invested in Quince Therapeutics in 2020 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 43 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
13.54% more ownership
Funds ownership: 38.95% → 52.49% (+14%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
83
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$86.2M | |
| 2 | +$36.8M | |
| 3 | +$11.7M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.97M |
| 5 |
ECG
EPIQ Capital Group
San Francisco,
California
|
+$6.86M |
Top Sellers
| 1 | -$1.14M | |
| 2 | -$659K | |
| 3 | -$402K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$287K |
| 5 |
N
Natixis
Paris,
France
|
-$204K |